Navios Maritime Acquisition Corp:企業のM&A・事業提携・投資動向

◆英語タイトル:Navios Maritime Acquisition Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2427
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:102
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:モナコ
◆産業分野:輸送・物流
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Navios Maritime Acquisition Corp – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Navios Maritime Acquisition Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Navios Maritime Acquisition Corp since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Navios Maritime Acquisition Corp’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Navios Maritime Acquisition Corp. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Navios Maritime Acquisition Corp’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Navios Maritime Acquisition Corp and its subsidiaries since 2007.
- Information about key financial and legal advisors for Navios Maritime Acquisition Corp’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Navios Maritime Acquisition Corp’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
MERGERS & ACQUISITIONS 7
Mergers and Acquisitions – Overview 7
Mergers and Acquisitions – Deal reports 8
CAPITAL RAISING 53
Capital Raising – Overview 53
Capital Raising – Deal reports 54
DIVESTMENTS 86
Divestments – Overview 86
Divestments – Deal reports 87
APPENDIX 92
Contact Us 92
About MarketLine Financial Deals Database 92
Deal Definition and Methodology 94
About MarketLine 101

List of Tables
Table 1: Navios Maritime Acquisition Corporation M&A volume and value trend (2014-YTD2018)
Table 2: Navios Maritime Acquisition Corporation capital raising volume and value trend (2014-YTD2018)
Table 3: Navios Maritime Acquisition Corporation capital raising by deal type (2014-YTD2018)
Table 4: Navios Maritime Acquisition Corporation divestments volume and value trend (2014-YTD2018)

List of Figures
Figure 1: Navios Maritime Acquisition Corporation M&A volume and value trend (2014-YTD2018)
Figure 2: Navios Maritime Acquisition Corporation capital raising volume and value trend (2014-YTD2018)
Figure 3: Navios Maritime Acquisition Corporation capital raising by deal type (2014-YTD2018)
Figure 4: Navios Maritime Acquisition Corporation divestments volume and value trend (2014-YTD2018)

★海外企業調査レポート[Navios Maritime Acquisition Corp:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Merz Pharma GmbH & Co KgaA:医療機器:M&Aディール及び事業提携情報
    Summary Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous …
  • Zymeworks Inc:企業のM&A・事業提携・投資動向
    Zymeworks Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Zymeworks Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Nezavisni operator sustava u Bosni i Hercegovini:企業の戦略的SWOT分析
    Nezavisni operator sustava u Bosni i Hercegovini - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Spectrum Health System:企業の戦略的SWOT分析
    Spectrum Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Grupo Televisa S.A.B.:企業の戦略・SWOT・財務情報
    Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report Summary Grupo Televisa S.A.B. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Biocodex Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocodex Inc (Biocodex), a subsidiary of Biocodex, is a pharmaceutical company that manufacturs and distributs probiotic drug products. The company provides products such as Saccharomyces boulardii CNCM I-745 that has a positive effect on the gut's microflora. It also provides Florastor, a y …
  • Ion Beam Applications SA (IBAB)-医療機器分野:企業M&A・提携分析
    Summary Ion Beam Applications SA (IBA) is a medical technology company that develops solutions for the diagnosis and treatment of cancer. It offers monitoring equipment and software that enables hospitals to perform calibration procedures during radiation therapy and radiology. The company focuses i …
  • Relation Insurance Services, Inc:企業の戦略・SWOT・財務情報
    Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report Summary Relation Insurance Services, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Century Casinos Inc:戦略・SWOT・企業財務分析
    Century Casinos Inc - Strategy, SWOT and Corporate Finance Report Summary Century Casinos Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Astaldi S.p.A.:戦略・SWOT・企業財務分析
    Astaldi S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Astaldi S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • RayBiotech Inc:医療機器:M&Aディール及び事業提携情報
    Summary RayBiotech Inc (RayBiotech) is a life science company that provides proteins, antibodies and immunological kits. The company's product categories include antibody arrays, glycobiology arrays, protein arrays, phosphorylation arrays, elisa, functional assays, antibodies and custom recombinant …
  • Filtronic plc:企業の戦略・SWOT・財務情報
    Filtronic plc - Strategy, SWOT and Corporate Finance Report Summary Filtronic plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Continental Resources Inc (CLR):企業の財務・戦略的SWOT分析
    Summary Continental Resources Inc (Continental Resources) is an independent upstream oil and gas company. The company explores for, develops and produces crude oil and natural gas. It operates in the onshore oil field, the Bakken of North Dakota and Montana; SCOOP play in Woodford reservoir; SCOOP S …
  • Drugs for Neglected Diseases initiative-製薬・医療分野:企業M&A・提携分析
    Summary Drugs for Neglected Diseases initiative (DNDi) is a research center that discovers and develops new drugs. The center develops therapeutics for the treatment of various diseases. It offers treatments which include ASAQ, ASMQ, NECT, SSG&PM and pediatric benznidazole. DNDi also offers products …
  • SINTEF:企業の戦略的SWOT分析
    SINTEF - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Safeguard Scientifics Inc (SFE):企業の財務・戦略的SWOT分析
    Summary Safeguard Scientifics Inc (Safeguard Scientifics), formerly Lancaster Corp, is a provider of finance, healthcare and digital media solutions. The company offers business intelligence and analytics for institutional/capital markets, insurance technology, regulatory and compliance technology a …
  • FluoroPharma Medical Inc (FPMI):企業の財務・戦略的SWOT分析
    Summary FluoroPharma Medical Inc (FluoroPharma) is a molecular imaging company that develops and commercialize proprietary medical diagnostic imaging products. The company develops breakthrough positron emission tomography imaging agents for the assessment and detection of acute and chronic forms of …
  • Chevalier International Holdings Ltd:企業の戦略・SWOT・財務情報
    Chevalier International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Chevalier International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Unichem Laboratories Ltd (UNICHEMLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Unichem Laboratories Ltd (Unichem) is an integrated, specialty pharmaceutical company which manufactures pharmaceutical formulations, generic products and active pharmaceutical ingredients (API's). The company offers its products in the therapeutic areas of gastroenterology, anti-invectives, …
  • BioElectronics Corp (BIEL):企業の製品パイプライン分析2018
    Summary BioElectronics Corp (BioElectronics) is a medical device company that provides non-invasive electroceuticals for the mitigation of neurological diseases. It develops, manufactures and markets non-invasive, drug-free, disposable pain therapy devices. The company’s products for pain relief inc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆